First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives [0.03%]
KRAS突变非小细胞肺癌一线治疗：现状与未来展望
Qi He,Xiaoyan Liu,Liyan Jiang et al.
Qi He et al.
KRAS mutations are common in non-small cell lung cancer (NSCLC) and are associated with patient prognosis; however, targeting KRAS has faced various difficulties. Currently, immunotherapy, chemotherapy, and chemoimmunotherapy play pivotal r...
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer [0.03%]
二氢乳酸作为胆道癌中一种有潜力的抗肿瘤生成剂
Celina Ablinger,Daniel Neureiter,Theresa Mähr et al.
Celina Ablinger et al.
Biliary tract cancer (BTC) is a rare malignancy with rising incidence. The therapeutic options are limited and the overall survival remains poor. Cyclin-dependent kinases, drivers of cell cycle and transcription have numerous biological fun...
Correction [0.03%]
更正通知书
Published Erratum
Cancer biology & therapy. 2024 Dec 31;25(1):2437847. DOI:10.1080/15384047.2024.2437847 2024
Targeting autophagy promotes the antitumor effect of radiotherapy on cervical cancer cells [0.03%]
靶向自噬可促进放射治疗对宫颈癌细胞的抗肿瘤效应
Fanjie Meng,Ying Yan,Li Zhou et al.
Fanjie Meng et al.
Radiotherapy is the mainstay of cancer treatment, and reducing radioresistance is still a poorly explored issue in radiotherapy. Our study was designed to explore the possible functions and mechanisms of autophagy in cervical cancer cells t...
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results [0.03%]
按摩治疗放射性纤维化的研究进展及触诊结果（动物实验）
Geoffrey M Bove,Holly McMillan,Mary F Barbe
Geoffrey M Bove
Radiation-induced fibrosis (RIF) is a common side effect of cancer treatment, but can manifest into a devastating syndrome for which there is no preventive measure or cure. In rats who perform a repetitive work task, who left untreated deve...
LCP1 promotes ovarian cancer cell resistance to olaparib by activating the JAK2/STAT3 signalling pathway [0.03%]
LCP1通过激活JAK2/STAT3信号通路促进卵巢癌细胞对奥拉帕尼的耐药性
Minxue Gai,Lanlan Zhao,Hongqi Li et al.
Minxue Gai et al.
Background: Resistance to poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis) remain a major challenge in ovarian cancer (OC) treatment. However, the underlying mechanism of PARPi resistance is still poorly characteri...
Liu-Shen-Wan inhibits PI3K/Akt and TRPV1 signaling alleviating bone cancer pain in rats [0.03%]
连参丸通过抑制PI3K/Akt和TRPV1信号减轻大鼠骨癌痛
Hui Zhang,Jingwen Jiang,Xuewu Chen et al.
Hui Zhang et al.
Patients with advanced-stage cancers often suffer from severe pain caused by bone metastasis and destruction, for which effective treatment options are limited. Liu-Shen-Wan (LSW) is a widely recognized herbal formula utilized for pain reli...
NAALADL2-AS2 functions as a competing endogenous RNA to regulate apoptosis and drug resistance in DLBCL [0.03%]
NAALADL2-AS2通过调控凋亡和耐药性在DLBCL中发挥竞争性内源RNA的作用
Xiaoli Xu,Juan Liu,Cheng Fang et al.
Xiaoli Xu et al.
To explore role of NAALADL2-AS2 as ceRNA in DLBCL. Fluorescence in situ hybridization was used to determine location of NAALADL2-AS2 in cells and to verify its expression in DLBCL tissues. The miRNAs interacting with NAALADL2-AS2 and relate...
PDLIM1, a novel miR-3940-5p target, regulates the malignant progression of diffuse large B-cell lymphoma [0.03%]
PDLIM1，miR-3940-5p的新靶基因，调控弥漫性大B细胞淋巴瘤恶性进展
Jinfeng Zhu,Huifang Xiao,Chuntuan Li et al.
Jinfeng Zhu et al.
Background: PDZ And LIM domain protein 1 (PDLIM1), a protein-coding gene, has been widely reported to exhibit differential expression patterns across various human cancers, including hematological malignancies. This study...
DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy [0.03%]
DSN1可能预示低级别胶质瘤患者的预后不良并可作为免疫治疗的潜在靶点
Yulong Jia,Meiling Liu,Han Liu et al.
Yulong Jia et al.
DSN1 has been previously found to be positively correlated with various cancers. However, the effect of DSN1 or its methylation on the prognosis, molecular characteristics, and immune cell infiltration of low-grade glioma (LGG) has not yet ...